Assessing Edwards Lifesciences: Insights From 14 Financial Analysts

Jan 12, 2024  · Analysts have set 12-month price targets for Edwards Lifesciences, revealing an average target of $76.71, a high estimate of $85.00, and a low estimate of $57.00.


Install CouponFollow Chrome Extension   CouponFollow Extension

$76.71
OFF

Assessing Edwards Lifesciences: Insights From 14 Financial Analysts

1 day from now

Jan 12, 2024  · Analysts have set 12-month price targets for Edwards Lifesciences, revealing an average target of $76.71, a high estimate of $85.00, and a low estimate of $57.00.

businessinsider.com

$74.33
OFF

Cracking The Code: Understanding Analyst Reviews For Edwards ...

1 day from now

Oct 25, 2024  · The 12-month price targets, analyzed by analysts, offer insights with an average target of $74.33, a high estimate of $90.00, and a low estimate of $66.00. ... Edwards …

nasdaq.com

$83.32
OFF

Analyst Scoreboard: 19 Ratings For Edwards Lifesciences

1 day from now

Sep 9, 2024  · The 12-month price targets, analyzed by analysts, offer insights with an average target of $83.32, a high estimate of $110.00, and a low estimate of $70.00. ... Edwards …

nasdaq.com

$96.45
OFF

Assessing Edwards Lifesciences: Insights From 11 Financial Analysts

1 day from now

Insights from analysts' 12-month price targets are revealed, presenting an average target of $96.45, a high estimate of $105.00, and a low estimate of $85.00. Witnessing a positive shift, …

capedge.com

$97
OFF

What Analysts Are Saying About Edwards Lifesciences Stock

1 day from now

May 30, 2024  · Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $97.4, a high estimate of $107.00, and a low estimate …

businessinsider.com

$96.45
OFF

Assessing Edwards Lifesciences: Insights From 11 Financial Analysts

1 day from now

Assessing Edwards Lifesciences: Insights From 11 Financial Analysts. ... Insights from analysts' 12-month price targets are revealed, presenting an average target of $96.45, a high estimate …

webull.com

6%
OFF

Edwards Lifesciences (EW) Q3 Earnings On The Horizon: Analysts

1 day from now

Oct 21, 2024  · In its upcoming report, Edwards Lifesciences (EW) is predicted by Wall Street analysts to post quarterly earnings of $0.67 per share, reflecting an increase of 13.6% …

nasdaq.com

31%
OFF

Edwards Lifesciences (EW) Faces Investor Class Action

1 day from now

3 days ago  · These events drove the price of Edwards Lifesciences shares down $27.25 (-31%) on July 25, 2024, wiping out over $16 billion of shareholder value in a single day.

morningstar.com

$87
OFF

What 9 Analyst Ratings Have To Say About Edwards Lifesciences

1 day from now

Mar 7, 2024  · Analysts have set 12-month price targets for Edwards Lifesciences, revealing an average target of $87.0, a high estimate of $95.00, and a low estimate of $77.00.

businessinsider.com

31%
OFF

Edwards Lifesciences (EW) Faces Investor Class Action Over

1 day from now

2 days ago  · These events drove the price of Edwards Lifesciences shares down $27.25 (-31%) on July 25, 2024, wiping out over $16 billion of shareholder value in a single day.

globenewswire.com

FAQs about Assessing Edwards Lifesciences: Insights From 14 Financial Analysts Coupon?

How do analysts evaluate Edwards Lifesciences (Els) stock?

Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Edwards Lifesciences compared to the broader market. Price Targets: Gaining insights, analysts provide estimates for the future value of Edwards Lifesciences's stock. ...

What is the price target for Edwards Lifesciences?

Analysts have set 12-month price targets for Edwards Lifesciences, revealing an average target of $76.71, a high estimate of $85.00, and a low estimate of $57.00. This current average represents a 10.36% decrease from the previous average price target of $85.58. ...

What is Edwards Lifesciences's debt-to-equity ratio?

Debt Management: Edwards Lifesciences's debt-to-equity ratio is below the industry average at 0.1, reflecting a lower dependency on debt financing and a more conservative financial approach. How Are Analyst Ratings Determined? ...

What does a rating mean for Edwards Lifesciences?

Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Edwards Lifesciences compared to the broader market. ...

How do analysts react to Edwards Lifesciences?

Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Edwards Lifesciences. ...

Who is investigating Edwards Lifesciences Corporation (EW)?

LOS ANGELES-- (BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Edwards Lifesciences Corporation (“Edwards Lifesciences” or the “Company”) (NYSE: EW) on behalf of investor... Get a real-time Edwards Lifesciences Corporation (EW) stock price quote with breaking news, financials, statistics, charts and more. ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension